LncRNA LINC00998 Inhibits the Malignant Glioma Phenotype Via the CBX3-mediated C-Met/Akt/mTOR Axis

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2020 Dec 3

PMID 33268783

Citations 37

Authors

Haiping Cai

Yanjiao Yu

Xiangrong Ni

Cong Li

Yuanjun Hu

Jing Wang

Furong Chen

Shaoyan Xi

Zhongping Chen

Affiliations

Soon will be listed here.

Abstract

Long noncoding RNAs (lncRNAs), once considered to be nonfunctional relics of evolution, are emerging as essential genes in tumor progression. However, the function and underlying mechanisms of lncRNAs in glioma remain unclear. This study aimed to investigate the role of LINC00998 in glioma progression. Through screening using TCGA database, we found that LINC00998 was downregulated in glioblastoma tissues and that low expression of LINC00998 was associated with poor prognosis. Overexpression of LINC00998 inhibited glioma cell proliferation in vitro and in vivo and blocked the G1/S cell cycle transition, which exerted a tumor-suppressive effect on glioma progression. Mechanistically, RNA pull-down and mass spectrometry results showed an interaction between LINC00998 and CBX3. IP assays demonstrated that LINC00998 could stabilize CBX3 and prevent its ubiquitination degradation. GSEA indicated that LINC00998 could regulate the c-Met/Akt/mTOR signaling pathway, which was further confirmed by a rescue assay using siRNA-mediated knockdown of CBX3 and the Akt inhibitor MK2206. In addition, dual-luciferase assays showed that miR-34c-5p could directly bind to LINC00998 and downregulate its expression. Our results identified LINC00998 as a novel tumor suppressor in glioma, and LINC00998 could be a novel prognostic biomarker, providing a strategy for precision therapy in glioma patients.

Citing Articles

Induction of the p21/CDK6 pathway and alteration of the immune microenvironment by the stem cell marker CBX3 in melanoma.

Chen W, Zhou L, Jiang J, Chen J, Geng D, Chen Y Stem Cell Res Ther. 2025; 16(1):63.

PMID: 39934923 PMC: 11816572. DOI: 10.1186/s13287-025-04179-8.

Long Non-Coding RNAs in Malignant Human Brain Tumors: Driving Forces Behind Progression and Therapy.

Pei D, Zhang D, Guo Y, Chang H, Cui H Int J Mol Sci. 2025; 26(2).

PMID: 39859408 PMC: 11766336. DOI: 10.3390/ijms26020694.

Xanthohumol overcomes osimertinib resistance via governing ubiquitination-modulated Ets-1 turnover.

Ma Y, Wang R, Liao J, Guo P, Wang Q, Li W Cell Death Discov. 2024; 10(1):454.

PMID: 39468027 PMC: 11519634. DOI: 10.1038/s41420-024-02220-y.

Regulation of autophagy by non-coding RNAs in human glioblastoma.

Molavand M, Ebrahimnezhade N, Kiani A, Yousefi B, Nazari A, Majidinia M Med Oncol. 2024; 41(11):260.

PMID: 39375229 DOI: 10.1007/s12032-024-02513-3.

Oligodendrocyte-specific expression of - suggests a role in myelination with prognostic value in oligodendroglioma.

de Los Angeles Becerra Rodriguez M, Gonzalez Munoz E, Moore T Noncoding RNA Res. 2024; 9(4):1061-1068.

PMID: 39022681 PMC: 11254506. DOI: 10.1016/j.ncrna.2024.06.008.

References

Wang Y, Wang Y, Ma L, Nie M, Ju J, Liu M . Heterochromatin Protein 1γ Is a Novel Epigenetic Repressor of Human Embryonic ϵ-Globin Gene Expression. J Biol Chem. 2017; 292(12):4811-4817. PMC: 5377797. DOI: 10.1074/jbc.M116.768515. View

Fu J, Yang Q, Sai K, Chen F, Pang J, Ng H . TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells. Neuro Oncol. 2013; 15(10):1353-65. PMC: 3779037. DOI: 10.1093/neuonc/not079. View

Hendriks I, DSouza R, Yang B, Verlaan-de Vries M, Mann M, Vertegaal A . Uncovering global SUMOylation signaling networks in a site-specific manner. Nat Struct Mol Biol. 2014; 21(10):927-36. PMC: 4259010. DOI: 10.1038/nsmb.2890. View

Molinaro A, Taylor J, Wiencke J, Wrensch M . Genetic and molecular epidemiology of adult diffuse glioma. Nat Rev Neurol. 2019; 15(7):405-417. PMC: 7286557. DOI: 10.1038/s41582-019-0220-2. View

Luo J, Wang K, Yeh S, Sun Y, Liang L, Xiao Y . LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling. Nat Commun. 2019; 10(1):2571. PMC: 6561926. DOI: 10.1038/s41467-019-09784-9. View

Chen X, Liang H, Zhang C, Zen K . miRNA regulates noncoding RNA: a noncanonical function model. Trends Biochem Sci. 2012; 37(11):457-9. DOI: 10.1016/j.tibs.2012.08.005. View

Wang Q, Zhang J, Liu Y, Zhang W, Zhou J, Duan R . A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma. Cancer Lett. 2016; 373(2):251-9. DOI: 10.1016/j.canlet.2016.01.039. View

Wu C, Chen C, Lin C, Feng L, Lin Y, Wei K . CCL5 of glioma-associated microglia/macrophages regulates glioma migration and invasion via calcium-dependent matrix metalloproteinase 2. Neuro Oncol. 2019; 22(2):253-266. PMC: 7032635. DOI: 10.1093/neuonc/noz189. View

Hendriks I, Treffers L, Verlaan-de Vries M, Olsen J, Vertegaal A . SUMO-2 Orchestrates Chromatin Modifiers in Response to DNA Damage. Cell Rep. 2015; 10(10):1778-1791. PMC: 4514456. DOI: 10.1016/j.celrep.2015.02.033. View

10.

Koike N, Maita H, Taira T, Ariga H . Identification of heterochromatin protein 1 (HP1) as a phosphorylation target by Pim-1 kinase and the effect of phosphorylation on the transcriptional repression function of HP1(1). FEBS Lett. 2000; 467(1):17-21. DOI: 10.1016/s0014-5793(00)01105-4. View

11.

Jin X, Kim L, Wu Q, Wallace L, Prager B, Sanvoranart T . Targeting glioma stem cells through combined BMI1 and EZH2 inhibition. Nat Med. 2017; 23(11):1352-1361. PMC: 5679732. DOI: 10.1038/nm.4415. View

12.

Cabili M, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A . Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011; 25(18):1915-27. PMC: 3185964. DOI: 10.1101/gad.17446611. View

13.

Fatica A, Bozzoni I . Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet. 2013; 15(1):7-21. DOI: 10.1038/nrg3606. View

14.

Chen F, Chen J, Yang L, Liu J, Zhang X, Zhang Y . Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat Cell Biol. 2019; 21(4):498-510. DOI: 10.1038/s41556-019-0299-0. View

15.

Li H, Jia Y, Cheng J, Liu G, Song F . LncRNA NCK1-AS1 promotes proliferation and induces cell cycle progression by crosstalk NCK1-AS1/miR-6857/CDK1 pathway. Cell Death Dis. 2018; 9(2):198. PMC: 5833418. DOI: 10.1038/s41419-017-0249-3. View

16.

Mo S, Zhang L, Dai W, Han L, Wang R, Xiang W . Antisense lncRNA LDLRAD4-AS1 promotes metastasis by decreasing the expression of LDLRAD4 and predicts a poor prognosis in colorectal cancer. Cell Death Dis. 2020; 11(2):155. PMC: 7048743. DOI: 10.1038/s41419-020-2338-y. View

17.

Zheng Y, Li L, Jia Y, Zhang B, Li J, Zhu Y . LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway. Theranostics. 2019; 9(3):796-810. PMC: 6376468. DOI: 10.7150/thno.28992. View

18.

Lachner M, OCarroll D, Rea S, Mechtler K, Jenuwein T . Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature. 2001; 410(6824):116-20. DOI: 10.1038/35065132. View

19.

Ma Q, Long W, Xing C, Chu J, Luo M, Wang H . Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma. Front Immunol. 2019; 9:2924. PMC: 6308128. DOI: 10.3389/fimmu.2018.02924. View

20.

Zhao Y, Zhang F, Pan Z, Luo H, Liu K, Duan X . LncRNA NR_003923 promotes cell proliferation, migration, fibrosis, and autophagy via the miR-760/miR-215-3p/IL22RA1 axis in human Tenon's capsule fibroblasts. Cell Death Dis. 2019; 10(8):594. PMC: 6685939. DOI: 10.1038/s41419-019-1829-1. View